Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
A deep learning technique was able to detect glaucoma with more accuracy than traditional approaches, according to a recent study conducted by IBM and New York University scientists.
Hospitals are becoming healthier places for patients, as healthcare-associated infections among hospital patients are declining, according to a recent CDC survey published in the New England Journal of Medicine.
Physicians with WellSpan Health, a Pennsylvania-based healthcare system, will now have access to a smartphone application that uses artificial intelligence to help people with diabetes.
A team of researchers used machine learning to help develop a model for predicting surgical critical care patients’ risk of developing hospital-acquired pressure injuries, according to a study published in the American Journal of Critical Care.
As CVS Health and Aetna are awaiting final regulatory approval for their $69 billion merger, Aetna, the nation’s third-largest health insurance provider, reported strong earnings during the third quarter of the year, with $1 billion income.
